The most important trend in managing the cost of drug benefit plans

Benefits Canada (June 2009)

Until recently, generic drugs have been an afterthought when it comes to looking at ways to contain drug costs in private plans. Expensive biological drugs and the high cost of “me-too” brand name drugs and brand-name line extensions that offer little (if any) additional value have been the headlines in this area for years. Download PDF


Latest News